Developing a new excipient and obtaining its market approval is an expensive, time-consuming, and complex process. The application of a multivariate analytical approach principal component analysis (PCA) - in combination with the design of experiments (DoE) approach can make the process of developing co-processed excipient cost-effective and rapid. The present investigation was aimed to demonstrate the applicability of the DoE approach and PCA in developing a co-processed excipient by using the spray drying technique. The preliminary studies suggested a significant effect of inlet air temperature ( ) and polymer ratio [chitosan chlorhydrate (CC): mannitol - ) on critical product characteristics so they were selected as independent variables in 3 full factorial design. The result of regression analysis suggested a significant effect of both independent variables on all response variables. The PCA of practically obtained value suggested a strong effect of all the selected response variables on the model. The prepared co-processed excipient had better tableting properties compared to the physical mixture of excipients and was able to accommodate more than 80% drug without compromising the flow property and compressibility. The present investigation successfully proved the applicability PCA and DoE approach as an effective and rapid tool for optimizing process parameters and formulation composition for preparing a directly compressible co-processed excipient.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03639045.2020.1841788DOI Listing

Publication Analysis

Top Keywords

co-processed excipient
16
doe approach
12
directly compressible
8
approach principal
8
principal component
8
component analysis
8
design experiments
8
developing co-processed
8
independent variables
8
response variables
8

Similar Publications

Kollidon® SR: Formulation techniques and drug delivery applications.

Int J Pharm

December 2024

Department of Pharmaceutical Sciences and Pharmaceutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan.

Kollidon® SR is one of the recent versatile coprocessed excipients in the formulation of modified-release dosage forms. It is prepared by co-spray drying aqueous dispersions of polyvinylacetate and polyvinylpyrrolidone. This article gives a critical review of the physicochemical attributes and technological properties of Kollidon® SR.

View Article and Find Full Text PDF

Evaluation of the Potential of Novel Co-Processed Excipients to Enable Direct Compression and Modified Release of Ibuprofen.

Pharmaceutics

November 2024

Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.

: Improving the production rates of modern tablet presses places ever greater demands on the performance of excipients. Although co-processing has emerged as a promising solution, there is still a lack of directly compressible excipients for modified-release formulations. The aim of the present study was to address this issue by investigating the potential of novel co-processed excipients for the manufacture of modified-release tablets containing ibuprofen.

View Article and Find Full Text PDF

Silicified microcrystalline cellulose from renewable banana pseudostem: Physicochemical and functional analysis.

Int J Biol Macromol

December 2024

Department of Pharmaceutical Science, Assam University, Silchar, Assam 788011, India. Electronic address:

Microcrystalline cellulose (MCC) has been isolated from numerous sources through acid hydrolysis of mercerized cellulose. Due to the fibrous shape, its poor flow ability and lower compactibility, MCC is often co-processed with other excipients to improve its functional properties. Musa MCC was isolated from the pseudostem of Musa balbisiana and silicified with 2 % silicon dioxide (SMCC) through homogenization followed by filtration and oven drying.

View Article and Find Full Text PDF

Background/objectives: Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive drugs.

Methods: Herein, the moisture sorption behavior of excipients and drug stability using aspirin as the model drug in matrix tablets were evaluated, using HPMC and the newly developed mannitol-coated HPMC, under accelerated stability conditions (40 °C, 75% relative humidity) with open and closed dishes.

View Article and Find Full Text PDF

Poor water solubility is an important challenge in the development of oral patient-friendly solid dosage forms. This study aimed to prepare orodispersible tablets with solid dispersions of a poorly water-soluble drug fenofibrate and a co-processed excipient consisting of mesoporous silica and isomalt. This co-processed excipient, developed in a previous study, exhibited improved flow and compression properties compared to pure silica while maintaining a high specific surface area for drug adsorption.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!